Loading data for ASTH — first visit, this takes a few seconds.

Preisalarm

Astrana Health Inc. (ASTH)

NasdaqCM: ASTH · Echtzeitkurs · USD

40.81

+3.02 (7.99%)

Zum Schluss: Aug 19, 2026, 6:25 PM

7.99% (1D)

Keine Daten verfügbar

Geld	26.36
Marktkapitalisierung	1.94 Mrd
Umsatz (TTM)	3.84 Mrd
Nettogewinn (TTM)	40.55 Mio
Beta	0.90
EPS (ttm)	0.82
KGV (TTM)	47.72
Forward-KGV	11.05
KBV (TTM)	2.32
KUV (TTM)	0.50
Earnings Date	Nov 5, 2026

Brief	47.23
Volumen	539,473
Ø Vol. (20D)	611,627
Eröffnung	37.69
Vortagesschluss	37.79
Tagesspanne	37.69 - 40.90
52-Wk Range	18.08 - 51.60
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über ASTH

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care ...

[Mehr lesen]

Branche Medical Care Facilities

Sektor Healthcare

IPO Datum Mar 11, 2009

Mitarbeiter 3,000

Börse NasdaqCM

Tickersymbol ASTH

Website https://www.astranahealth.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Astrana Health 3.18 Mrd, ein Anstieg von 56.39% im Vergleich zum Vorjahr (2.03 Mrd). Der Gewinn lag bei 22.49 Mio, ein Rückgang von -47.89 %.

Finanzberichte

Gewinnüberraschung

Astrana Health hat die Quartalszahlen am Aug 6, 2026 veröffentlicht:

Umsatz von n/a verfehlt die Erwartungen um $0, mit -100.00% Rückgang im Jahresvergleich.

EPS von 0.8 übertrifft die Erwartungen um 0.07, mit 37.93% Wachstum im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Astrana Health Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 5, 2026, während der Handelszeiten.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 5 Tagen · Motley Fool

Astrana Health (ASTH) Q2 2026 Earnings Call Transcript

Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80.

vor 1 Woche · StockStory

ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook

Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next quarter’s revenue guidance of $1.02 billion...

vor 1 Woche · Simply Wall St.

Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress

Astrana Health now sits on a modestly higher fair value estimate, with the modeled price moving from about US$47.11 to about US$50.13 per share. That shift lines up with analyst commentary that weighs...

vor 1 Woche · GuruFocus.com

Astrana Health Inc (ASTH) (Q2 2026) Earnings Call Highlights: Record EPS and Raised Guidance ...

Astrana Health Inc (ASTH) delivers 49% revenue growth and raises full-year adjusted EBITDA guidance to $255-$280 million.

vor 1 Woche · Zacks

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Seite 1 von 2

Astrana Health Inc. (ASTH)